Form 4 for LRCX Lam Research
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-20 · accession 0000707549-25-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-21 | 2025-02-20 | LRCX | Varadarajan Seshasayee | SVP | M - OptEx | $18.11 | +110.1K | 253.4K | +77% | +$1.99M |
| DM | 2025-02-21 | 2025-02-20 | LRCX | Varadarajan Seshasayee | SVP | S - Sale+OE | $90.00 | -110.1K | 179.1K | -38% | -$9.91M |
| DM | 2025-02-21 | 2025-02-20 | LRCX | Varadarajan Seshasayee | SVP | M - OptEx | $18.11 | -110.1K | 0 | -100% | -$1.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | M | A | 35,760 | $19.01 | 214,844 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2025-02-20 | S | D | 35,760 | $90.00 | 179,084 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2025-02-20 | M | A | 74,320 | $17.68 | 253,404 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Common | Common Stock | 2025-02-20 | S | D | 74,320 | $90.00 | 179,084 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2025-02-20 | M | D | 74,320 | $17.68 | 0 | D | $17.68 · — to 2026-03-01 | 74,320 Common Stock | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024. (F4) The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-02-20 | M | D | 35,760 | $19.01 | 0 | D | $19.01 · — to 2025-03-01 | 35,760 Common Stock | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2024. (F3) The stock options will become exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021. |